Offer for Germany’s leading generic producer

The management of Stada Arzneimittel AG, Germany’s leading generics producer, has accepted a €4.1 billion offer for the company from two private equity firms, Bain Capital Private Equity LP of Boston Massachusetts, US and Cinven Partners LLP of London, UK.

Full text available to subscribers only. Click here for information on subscribing to MedNous.